- Lead Partner
- The organization designated as the primary contact with funders, regulators, and the public — typically responsible for grant reporting and fiscal oversight.
- Sub-Recipient
- A partner organization that receives a portion of grant funds passed through the lead partner and is subject to the same compliance obligations as the lead.
- Fiscal Sponsorship
- An arrangement where an established nonprofit holds tax-exempt status and funds on behalf of a project or smaller organization that lacks its own 501(c)(3) status.
- In-Kind Contribution
- Non-cash support — such as staff time, facilities, equipment, or services — provided by a partner in lieu of or in addition to monetary funding.
- Joint Governance Committee
- A decision-making body composed of representatives from each partner organization, responsible for overseeing program delivery and resolving disputes.
- Intellectual Property (IP)
- Copyrights, trademarks, training materials, curricula, software, and other intangible assets created or contributed to the collaboration.
- Cause-Marketing Agreement
- A commercial arrangement where a for-profit company promotes a nonprofit's mission in connection with product sales, with a defined portion of proceeds donated.
- Restricted Funds
- Grant or donor funds designated for a specific purpose that cannot legally be redirected to other uses without funder approval.
- Indemnification
- A contractual obligation by one party to compensate the other for losses, damages, or legal costs arising from defined acts or omissions.
- Wind-Down Clause
- A provision specifying how remaining assets, liabilities, data, and obligations are allocated among partners when the collaboration ends.
- Material Breach
- A failure to perform a core obligation under the agreement — such as misusing restricted funds — that entitles the non-breaching party to terminate immediately.
- Co-Applicant
- An organization that signs a grant application alongside the lead applicant and shares accountability for program outcomes and compliance.